The COVID Project
The record
- Jurisdiction
- United States (federal); Food and Drug Administration
- Level
- Federal
- Authority
- FD&C Act s. 564(c), (d)
- Issued
- 2020-04-13 Apr. 13, 2020
- Effective
- 2020-04-09
- End
- Through the public health emergency (read as 2021-09-30)
- In force
- Apr. 9, 2020 to Sept. 30, 2021
- Quarters
- 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3
2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3
- Limitation types
- Health care ordersSupply chain
- Addressees
- manufacturers of face shields; health care personnel; hospital purchasing departments and distributors
- Functions reached
- SC supply chain
- PF production floor (converted plastics and printing firms)
- Collection
- Other federal health agencies AGY-FED-HEALTH-OTHER
Operative words
On April 9, 2020, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) in response to concerns relating to insufficient supply and availability of face shields for use by health care personnel (HCP) as personal protective equipment (PPE) in healthcare settings... I am authorizing the emergency use of certain face shields for use by HCP as PPE in health care settings in accordance with CDC recommendations
Enforcement
Conditions of authorization